Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer

Objective Using whole genome sequencing, we identified gene amplification of solute carrier family 12 member 5 (SLC12A5) located at 20q13.12 in colorectal cancer (CRC). We analysed its amplification, overexpression, biological effects and prognostic significance in CRC. Design SLC12A5 amplification status was evaluated by fluorescence in situ hybridisation (FISH). The effects of SLC12A5 re-expression or knockdown were determined in proliferation, apoptosis, invasion and metastasis assays. SLC12A5 target genes and related pathways were identified by reporter activity and cDNA microarray analyses. Clinical impact of SLC12A5 overexpression was assessed in 195 patients with CRC. Results Amplification of SLC12A5 was verified in 78 out of 191 (40.8%) patients with primary CRC by FISH, which was positively correlated with its protein overexpression (p<0.001). Biofunctional investigation of SLC12A5 revealed that SLC12A5 significantly increased cell proliferation, G1-S cell cycle transition, invasion/migration abilities, but suppressed apoptosis in vitro and promoted xenograft tumour growth as well as lung metastasis in vivo. The antiapoptosis effect by SLC12A5 was mediated through inhibiting apoptosis-inducing factor and endonuclease G-dependent apoptotic signalling pathway; and the pro-metastasis role was by regulating key elements of the matrix architecture, including matrix metallopeptidase and fibronectin. After a median follow-up of 50.16 months, multivariate analysis revealed that patients with SLC12A5 protein overexpression had a significant decrease in overall survival. Kaplan–Meier survival curves showed that SLC12A5 overexpression was significantly associated with shortened survival in patients with CRC. Conclusions SLC12A5 plays a pivotal oncogenic role in colorectal carcinogenesis; its overexpression is an independent prognostic factor of patients with CRC.

[1]  Chang Yu,et al.  Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer , 2014, Gut.

[2]  Jian Wang,et al.  Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing , 2014, Cell Research.

[3]  D. Lodygin,et al.  IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis. , 2014, The Journal of clinical investigation.

[4]  Jianren Gu,et al.  Amplification of MPZL1/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma , 2013, Cell Research.

[5]  M. Jiang,et al.  CSE1L modulates Ras-induced cancer cell invasion: correlation of K-Ras mutation and CSE1L expression in colorectal cancer progression. , 2013, American journal of surgery.

[6]  J. Hurley,et al.  The molecular genetics of colorectal cancer , 2013, Frontline Gastroenterology.

[7]  S. Baumgartner-Parzer,et al.  Increased copy-number and not DNA hypomethylation causes overexpression of the candidate proto-oncogene CYP24A1 in colorectal cancer , 2013, International journal of cancer.

[8]  Jun Yu,et al.  Host immune defense peptide LL-37 activates caspase-independent apoptosis and suppresses colon cancer. , 2012, Cancer research.

[9]  J. Lamb,et al.  A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations , 2012, PloS one.

[10]  Changhong Sun,et al.  Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis. , 2011, Nature communications.

[11]  C. Akerman,et al.  The potassium–chloride cotransporter 2 promotes cervical cancer cell migration and invasion by an ion transport‐independent mechanism , 2011, The Journal of physiology.

[12]  S. Lam,et al.  TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer. , 2011, The Journal of clinical investigation.

[13]  Jun Yu,et al.  Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival , 2011, Gut.

[14]  X. Bian,et al.  Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial–mesenchymaltransition , 2011, Gut.

[15]  M. Pavlyukov,et al.  Survivin Monomer Plays an Essential Role in Apoptosis Regulation* , 2011, The Journal of Biological Chemistry.

[16]  Arnulf Stenzl,et al.  Fibronectin 1 mRNA expression correlates with advanced disease in renal cancer , 2010, BMC Cancer.

[17]  H. Grabsch,et al.  Candidate driver genes in focal chromosomal aberrations of stage II colon cancer , 2010, The Journal of pathology.

[18]  Takanobu Yamada,et al.  Overexpression of MMP-13 gene in colorectal cancer with liver metastasis. , 2010, Anticancer research.

[19]  P. Heikkilä,et al.  Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth. , 2010, The American journal of pathology.

[20]  S. Leung,et al.  Prognostic relevance of DNA copy number changes in colorectal cancer , 2010, The Journal of pathology.

[21]  Derek Y. Chiang,et al.  The landscape of somatic copy-number alteration across human cancers , 2010, Nature.

[22]  B. Ylstra,et al.  DNA copy number profiles of primary tumors as predictors of response to chemotherapy in advanced colorectal cancer. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[23]  W. Jiang,et al.  Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. , 2009, European journal of cancer.

[24]  Eytan Domany,et al.  Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer , 2009, Proceedings of the National Academy of Sciences.

[25]  S. Waldman,et al.  Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9. , 2009, Cancer research.

[26]  M. Ligtenberg,et al.  Predisposition to colorectal cancer: exploiting copy number variation to identify novel predisposing genes and mechanisms , 2009, Cytogenetic and Genome Research.

[27]  T. Furuya,et al.  Identification of DNA copy number aberrations associated with metastases of colorectal cancer using array CGH profiles. , 2009, Cancer genetics and cytogenetics.

[28]  F. Chan,et al.  Asia Pacific consensus recommendations for colorectal cancer screening , 2008, Gut.

[29]  Nektarios Tavernarakis,et al.  No death without life: vital functions of apoptotic effectors , 2008, Cell Death and Differentiation.

[30]  G. Stoica,et al.  MMP2 role in breast cancer brain metastasis development and its regulation by TIMP2 and ERK1/2 , 2007, Clinical & Experimental Metastasis.

[31]  Hanlee P. Ji,et al.  Molecular inversion probe analysis of gene copy alterations reveals distinct categories of colorectal carcinoma. , 2006, Cancer research.

[32]  Eytan Domany,et al.  Relationship of gene expression and chromosomal abnormalities in colorectal cancer. , 2006, Cancer research.

[33]  Shaji K. Kumar,et al.  Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway , 2005, Oncogene.

[34]  M. Schwaiger,et al.  CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. , 2005, Gastroenterology.

[35]  G. Giaccone,et al.  Cell Death Independent of Caspases: A Review , 2005, Clinical Cancer Research.

[36]  A. Krensky,et al.  A novel apoptosis pathway activated by the carboxyl terminus of p21. , 2005, Blood.

[37]  Jane Fridlyand,et al.  High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. , 2004, Carcinogenesis.

[38]  D. Mount,et al.  Molecular physiology of cation-coupled Cl− cotransport: the SLC12 family , 2004, Pflügers Archiv.

[39]  D. Grossman,et al.  Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells , 2004, Oncogene.

[40]  D. Xie,et al.  Heterogeneous expression and association of β‐catenin, p16 and c‐myc in multistage colorectal tumorigenesis and progression detected by tissue microarray , 2003, International journal of cancer.

[41]  F. Cecconi,et al.  Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak‐mediated permeabilization , 2003, The EMBO journal.

[42]  Bauke Ylstra,et al.  Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high‐resolution microarray comparative genomic hybridization , 2003, The Journal of pathology.

[43]  A. George,et al.  Molecular, functional, and genomic characterization of human KCC2, the neuronal K-Cl cotransporter. , 2002, Brain research. Molecular brain research.

[44]  Scott W. Lowe,et al.  Apoptosis A Link between Cancer Genetics and Chemotherapy , 2002, Cell.

[45]  X. Guan,et al.  Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. , 2001, Cancer research.

[46]  F. Schmitz,et al.  Functional Expression of HGF and Its Receptor in Human Colorectal Cancer , 2000, Digestion.

[47]  H. McLeod,et al.  Comparative genomic hybridization and chromosomal instability in solid tumours , 1999, British Journal of Cancer.

[48]  J. A. Payne,et al.  Molecular Characterization of a Putative K-Cl Cotransporter in Rat Brain , 1996, The Journal of Biological Chemistry.

[49]  Thomas Ried,et al.  Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors , 1996, Genes, chromosomes & cancer.

[50]  D. Lodygin,et al.  IL-6 R / STAT 3 / miR-34 a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis , 2018 .

[51]  Nomesh K Gopalani,et al.  Cooperativity between inhibition of cytosolic K+ efflux and AMPK activation during suppression of hypoxia-induced cellular apoptosis. , 2012, The international journal of biochemistry & cell biology.

[52]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.